Overview | Medtronic
Medtronic Investors

Creating
Long-term
Shareholder
Value

Our leading technologies and services create value on a global scale.

Learn More

Latest Investor Information

May 25, 2017
Q4 2017 Medtronic plc Earnings Conference Call
June 02, 2017
Medtronic plc at the Bernstein Thirty-Third Annual Strategic Decisions Conference

Latest Press Releases

May 18, 2017Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year
May 17, 2017Medtronic Study Finds High Use of App-Based Remote Cardiac Monitoring Among Older Patients
May 16, 2017Medtronic EVP & President Bryan Hanson to Speak at Jefferies 2017 Global Healthcare Conference
May 16, 2017New Data on CoreValve(TM) and Evolut(TM) R Self-Expanding TAVI Systems Show Excellent Clinical Outcomes in Routine Clinical Practice
Read More

Medtronic Dividend

Tax Treatment

Medtronic Dividend U.S. Tax Treatment & Return of Capital
(ROC) Basis Adjustments

LEARN MORE

Opportunities to Obtain Irish Dividend Withholding Tax (DWT) Exemption

Important Information on the Irish Dividend Withholding Tax.

LEARN MORE

QUARTERLY

RESULTS

Medtronic Q3 revenue results and financial tables.

LEARN MORE

INVESTOR

FUNDAMENTALS

View snapshots of revenue and earnings, trading statistics, balance sheet, income statement, cash flow and ratios.

LEARN MORE
img.alt

Sustainability Index Endorsements

Read more about our Sustainability efforts.

READ MORE
 
img.alt

Medtronic Spotlight

CNBC’s Meg Tirrell talks to Medtronic CEO Omar Ishrak at the Piper Jaffray Healthcare Heartland Summit about growth, pricing and other challenges facing the industry.

Play Video
 
img.alt

Focus on Patients

The personal connection between Medtronic plc, its employees and patients.

Play Video
 
img.alt

History of Medtronic

A video history of the company.

Play Video

Investor Contacts

Stock Transfer Agent

Wells Fargo Shareowner Services
+1 888-648-8154

Medtronic Investor Relations Department

investor.relations@medtronic.com

+1 763-505-2692

Ryan Weispfenning

Vice President, Investor Relations

View All
X